ses.
deCODE is a global leader in gene discovery -- our population approach and
resources have enabled us to isolate key genes contributing to major public
health challenges from cardiovascular disease to cancer, genes that are
providing us with drug targets rooted in the basic biology of disease.
deCODE is also leveraging its expertise in human genetics and integrated
drug discovery and development capabilities to offer innovative products
and services in DNA-based diagnostics, bioinformatics, genotyping,
structural biology, drug discovery and clinical development. deCODE is
delivering on the promise of the new genetics.SM Visit us on the web at
http://www.decode.com; on our diagnostics website at
http://www.decodediagnostics.com;
and, for our pioneering personal genome analysis service, at
http://www.decodeme.com.
Any statements contained in this presentation that relate to future
plans, events or performance are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially from
those described in the forward- looking statements. These risks and
uncertainties include, among others, those relating to technology and
product development, integration of acquired businesses, market acceptance,
government regulation and regulatory approval processes, intellectual
property rights and litigation, dependence on collaborative relationships,
ability to obtain financing, competitive products, industry trends and
other risks identified in deCODE's filings with the Securities and Exchange
Commission. deCODE undertakes no obligation to update or alter these
forward-looking statements as a result of new information, future events or
other
'/>"/>
SOURCE deCODE genetics Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference2.
deCODE Launches deCODEme(TM)3.
deCODE genetics Announces Third Quarter 2007 Financial Results4.
deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results5.
deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference6.
Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus7.
GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen8.
Healionics Corporation Announces Partnership to Develop and Distribute STARcuff(TM)9.
NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System10.
Nanotechnology innovation may revolutionize gene detection in a single cell11.
Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow